nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica
|
Kermani, Tanaz A. |
|
2014 |
|
1 |
p. 8-19 |
artikel |
2 |
A narrative review on the difficulties associated with fibromyalgia diagnosis
|
Kumbhare, Dinesh |
|
2018 |
|
1 |
p. 13-26 |
artikel |
3 |
An autumn tale: geriatric rheumatoid arthritis
|
Kobak, Senol |
|
2018 |
|
1 |
p. 3-11 |
artikel |
4 |
Anti-TNF therapy in ankylosing spondylitis: insights for the clinician
|
Coates, Laura C. |
|
2010 |
|
1 |
p. 37-43 |
artikel |
5 |
Assessing adherence to teriparatide therapy, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture
|
Mulgund, Manisha |
|
2009 |
|
1 |
p. 5-11 |
artikel |
6 |
Axial spondyloarthritis: is there a treatment of choice?
|
Poddubnyy, Denis |
|
2013 |
|
1 |
p. 45-54 |
artikel |
7 |
Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis
|
Komm, Barry S. |
|
2012 |
|
1 |
p. 21-34 |
artikel |
8 |
Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug
|
Bianchi, Gerolamo |
|
2010 |
|
1 |
p. 29-35 |
artikel |
9 |
Bone health in HIV and hepatitis B or C infections
|
Biver, Emmanuel |
|
2017 |
|
1 |
p. 22-34 |
artikel |
10 |
Current evidence for osteoarthritis treatments
|
Anandacoomarasamy, Ananthila |
|
2010 |
|
1 |
p. 17-28 |
artikel |
11 |
Denosumab in postmenopausal osteoporosis: what the clinician needs to know
|
Lewiecki, E. Michael |
|
2009 |
|
1 |
p. 13-26 |
artikel |
12 |
Editorial
|
Sambrook, Philip |
|
2009 |
|
1 |
p. 3-4 |
artikel |
13 |
Efficacy of vitamin E in knee osteoarthritis management of North Indian geriatric population
|
Bhattacharya, Ijen |
|
2012 |
|
1 |
p. 11-19 |
artikel |
14 |
Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review
|
van Eekeren, Inge C.M. |
|
2013 |
|
1 |
p. 33-44 |
artikel |
15 |
Fibrin glue for olecranon bursitis: a case report
|
Berkoff, David J. |
|
2016 |
|
1 |
p. 28-30 |
artikel |
16 |
Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects
|
Hunter, David J. |
|
2009 |
|
1 |
p. 35-47 |
artikel |
17 |
Fragility fracture: recent developments in risk assessment
|
Aspray, Terry J. |
|
2015 |
|
1 |
p. 17-25 |
artikel |
18 |
Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation
|
Corallo, Claudio |
|
2017 |
|
1 |
p. 3-10 |
artikel |
19 |
Impact of physical activity and mechanical loading on biomarkers typically used in osteoarthritis assessment: current concepts and knowledge gaps
|
Cattano, Nicole M. |
|
2017 |
|
1 |
p. 11-21 |
artikel |
20 |
Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks?
|
Clark, Emma M. |
|
2015 |
|
1 |
p. 11-16 |
artikel |
21 |
Is remission a more realistic goal in psoriatic arthritis?
|
Saber, Tajvur P. |
|
2011 |
|
1 |
p. 3-7 |
artikel |
22 |
Juvenile dermatomyositis: new insights and new treatment strategies
|
Martin, Neil |
|
2012 |
|
1 |
p. 41-50 |
artikel |
23 |
Latest therapeutic advances in musculoskeletal disease from the ACR 2015 annual conference
|
Reid, David M. |
|
2016 |
|
1 |
p. 8-14 |
artikel |
24 |
Osteoporosis in men: findings from the Osteoporotic Fractures in Men Study (MrOS)
|
Cawthon, Peggy M. |
|
2016 |
|
1 |
p. 15-27 |
artikel |
25 |
Osteoporosis therapeutics: recent developments at ASBMR
|
Mallarkey, Gordon |
|
2016 |
|
1 |
p. 3-7 |
artikel |
26 |
Physical functioning measures and risk of falling in older people living in residential aged care facilities
|
Wilson, Nicholas |
|
2011 |
|
1 |
p. 9-15 |
artikel |
27 |
Preference, satisfaction and usability of subcutaneously administered methotrexate for rheumatoid arthritis or psoriatic arthritis: results of a postmarketing surveillance study with a high-concentration formulation
|
Striesow, Frank |
|
2012 |
|
1 |
p. 3-9 |
artikel |
28 |
Review: Cutaneous side effects of antiosteoporosis treatments
|
Musette, Philippe |
|
2011 |
|
1 |
p. 31-41 |
artikel |
29 |
Review: Malignancy risk in vasculitis
|
Kermani, Tanaz A. |
|
2011 |
|
1 |
p. 55-63 |
artikel |
30 |
Review: Medical treatment of osteoporotic vertebral fractures
|
Langdahl, Bente Lomholt |
|
2011 |
|
1 |
p. 17-29 |
artikel |
31 |
Review: Recent advances in imaging in psoriatic arthritis
|
Panduro Poggenborg, René |
|
2011 |
|
1 |
p. 43-53 |
artikel |
32 |
Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome
|
Rodríguez-Pintó, Ignasi |
|
2015 |
|
1 |
p. 26-30 |
artikel |
33 |
Sarcoidois: is it only a mimicker of primary rheumatic disease? A single center experience
|
Kobak, Şenol |
|
2014 |
|
1 |
p. 3-7 |
artikel |
34 |
Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis
|
Henrotin, Yves |
|
2014 |
|
1 |
p. 20-34 |
artikel |
35 |
The effects of neuromuscular taping on gait walking strategy in a patient with joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type
|
Camerota, Filippo |
|
2015 |
|
1 |
p. 3-10 |
artikel |
36 |
The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential
|
Cutolo, Maurizio |
|
2013 |
|
1 |
p. 3-11 |
artikel |
37 |
Treating reactive arthritis: insights for the clinician
|
Carter, John D. |
|
2010 |
|
1 |
p. 45-54 |
artikel |
38 |
Treatment of glucocorticoid-induced osteoporosis
|
Mazziotti, Gherardo |
|
2009 |
|
1 |
p. 27-34 |
artikel |
39 |
Treatment of rheumatoid arthritis in patients with concomitant chronic hepatitis C infection
|
Joseph, Amy M. |
|
2012 |
|
1 |
p. 35-40 |
artikel |
40 |
Wnt signaling in bone formation and its therapeutic potential for bone diseases
|
Kim, Jeong Hwan |
|
2013 |
|
1 |
p. 13-31 |
artikel |
41 |
Zoledronic acid for the treatment and prevention of primary and secondary osteoporosis
|
Rizzoli, René |
|
2010 |
|
1 |
p. 3-16 |
artikel |